Project Details
| Status | Active |
|---|---|
| Effective start/end date | 3/6/23 → 11/30/26 |
Funding
- INC Research, LLC (BN42489 AMD 2 // BN42489 AMD 2)
- Genentech, Inc (BN42489 AMD 2 // BN42489 AMD 2)
(OE) Prot# BN42489: A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Evaluate the Safety, Biomakers, and Efficacy of Tominersen in Individuals with Prodromal and Early Manifest Hungtington's Disease
- Bega, Danny (PD/PI)
Project: Research project